HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

Mostrar otras versiones (1)

HORMA domain-containing protein 1 (HORMAD1), is normally expressed only in the germline, but is frequently re-activated in human triple-negative breast cancer (TNBC); however, its function in TNBC is largely unknown. In the present study, the expression and biological significance of HORMAD1 in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Beige, Sun, Lu, Peng, Yang, Wang, Yihua, Yu, Yu, Lei, Jinwei, Zhang, Yingzi, Guo, Shipeng, Li, Kang, Liu, Shengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165579/
https://www.ncbi.nlm.nih.gov/pubmed/34036395
http://dx.doi.org/10.3892/or.2021.8089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165579/
https://www.ncbi.nlm.nih.gov/pubmed/34036395
http://dx.doi.org/10.3892/or.2021.8089

Ejemplares similares